Actuate Therapeutics ACTU
NASDAQ ACTU
$0.78 +0.09 (+13.04%)
At close: Sep 30, 2026 · 4:00 PM EDT

Actuate Therapeutics (ACTU) Net Income (2023 - 2026)

Updated

Actuate Therapeutics' Net Income was -$4.87 million in Q2 2026, compared with -$5.95 million a year earlier.

Analysis

Actuate Therapeutics (ACTU) Net Income (2023 - 2026) Analysis & Trends

On a trailing twelve-month basis, Actuate Therapeutics' Net Income was -$20.78 million through Jun 30, 2026; for FY2025, it was -$22.23 million.

  • In earlier years, Net Income was -$24.96 million in FY2024 and -$24.66 million in FY2023.
  • Quarterly Net Income has moved between -$7.76 million (Q1 2024) and -$4.55 million (Q4 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 5.53 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.62 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 3.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.51 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.38 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -10.50 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -237.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.10 Bn
10 Actuate Therapeutics 18.73 Mn 18.73 Mn - -4.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.87 Mn
Dec 31, 2025 -4.55 Mn
Sep 30, 2025 -5.41 Mn
Jun 30, 2025 -5.95 Mn
Mar 31, 2025 -6.32 Mn
Dec 31, 2024 -6.45 Mn
Sep 30, 2024 -5.32 Mn
Jun 30, 2024 -5.43 Mn
Mar 31, 2024 -7.76 Mn
Dec 31, 2023 -7.56 Mn
Sep 30, 2023 -6.35 Mn
Jun 30, 2023 -5.59 Mn
API Access

Actuate Therapeutics Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=ACTU&period=max&api_key=YOUR_API_KEY